Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10087178
APP PUB NO 20170044156A1
SERIAL NO

14758082

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a substituted spiropyrido[1,2-a]pyrazine derivative or a pharmaceutically acceptable salt thereof, which is useful as an anti-HIV agent. The present invention relates to a compound represented by the following formula [I] or [II] or a pharmaceutically acceptable salt thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JAPAN TOBACCO INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Isoshima, Hirotaka Osaka, JP 9 314
Kawashita, Seiji Osaka, JP 6 140
Miyazaki, Susumu Osaka, JP 99 1099
Nagahashi, Noboru Osaka, JP 4 102
Oshita, Kengo Osaka, JP 6 140
Terashita, Masakazu Osaka, JP 8 110

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 2, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 2, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00